Journal of Clinical Oncology Issues Research Articles in Aug. 20, 2024 Edition
August 19, 2024
August 19, 2024
ALEXANDRIA, Virginia, Aug. 19 -- The Journal of Clinical Oncology, a journal from the American Society of Clinical Oncology that says it disseminates clinical oncology research, published research articles on the following topics in its Aug. 20, 2024, edition (Vol. 42, Issue 24):
* Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)
* Sacituzumab Govitecan Versus Docetaxel for Previously Tre . . .
* Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)
* Sacituzumab Govitecan Versus Docetaxel for Previously Tre . . .